南亚和东南亚外部质量保证网络:同一卫生部门参考实验室国际质量保证规划的经验和结果。

IF 3.9 2区 医学 Q1 INFECTIOUS DISEASES
Tomislav Kostyanev, Hiba Al-Mir, Kristi Prifti, Lone Brink Rasmussen, Freshwork Ayalew Abegaz, Patrícia Teixeira Dos Santos, Soo-Young Kwon, Rangsiya Prathan, Taradon Luang Tongkum, Pattrarat Chanchaithong, Pitak Santanirand, Watcharaporn Kamjumphol, Ondari D Mogeni, Tobin Guarnacci, Nimesh Poudyal, Marianne Holm, Wantana Paveenkittiporn, Rungtip Chuanchuen, Rene S Hendriksen
{"title":"南亚和东南亚外部质量保证网络:同一卫生部门参考实验室国际质量保证规划的经验和结果。","authors":"Tomislav Kostyanev, Hiba Al-Mir, Kristi Prifti, Lone Brink Rasmussen, Freshwork Ayalew Abegaz, Patrícia Teixeira Dos Santos, Soo-Young Kwon, Rangsiya Prathan, Taradon Luang Tongkum, Pattrarat Chanchaithong, Pitak Santanirand, Watcharaporn Kamjumphol, Ondari D Mogeni, Tobin Guarnacci, Nimesh Poudyal, Marianne Holm, Wantana Paveenkittiporn, Rungtip Chuanchuen, Rene S Hendriksen","doi":"10.1093/jac/dkaf032","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>External quality assurance (EQA) is an objective tool to assess laboratories' diagnostic performance and their adherence to recognized international standards. External Quality Assessment in Asia (EQASIA) is an EQA network in South and South-East Asia established in 2020 with the aim of improving the quality of bacteriology diagnostics across all One Health sectors in the region. The aim of this paper is to provide a comprehensive overview of the EQA results collected from the EQASIA network and to assess improvements among the participating laboratories.</p><p><strong>Methods: </strong>Six EQA rounds were conducted between 2021 and 2023, each composed of different panels of WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) and The Food and Agriculture Organization of the United Nations (FAO) priority pathogens of interest to both the human and animal health sector.</p><p><strong>Results: </strong>Between 24 and 32 laboratories signed up for six EQA rounds (EQA1-6). Participating laboratories were able to isolate and correctly identify most of the isolates across the EQA panels except for the Campylobacter spp. and Enterococcus spp. panels. The overall performance of laboratories across the six EQAs was between 75% and 100% (average 93.3% and median 93.6%). The obtained results showed a significant improvement in laboratories' performance over time.</p><p><strong>Conclusions: </strong>Laboratory capacity development and quality assurance in a microbiology laboratory are of particular importance especially in the context of antimicrobial resistance (AMR) and One Health surveillance. The EQASIA programme has the potential to validate laboratories' performance in detecting important One Health pathogens, generating reliable data for effective surveillance to curb AMR.</p>","PeriodicalId":14969,"journal":{"name":"Journal of Antimicrobial Chemotherapy","volume":" ","pages":"1037-1046"},"PeriodicalIF":3.9000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11962387/pdf/","citationCount":"0","resultStr":"{\"title\":\"External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.\",\"authors\":\"Tomislav Kostyanev, Hiba Al-Mir, Kristi Prifti, Lone Brink Rasmussen, Freshwork Ayalew Abegaz, Patrícia Teixeira Dos Santos, Soo-Young Kwon, Rangsiya Prathan, Taradon Luang Tongkum, Pattrarat Chanchaithong, Pitak Santanirand, Watcharaporn Kamjumphol, Ondari D Mogeni, Tobin Guarnacci, Nimesh Poudyal, Marianne Holm, Wantana Paveenkittiporn, Rungtip Chuanchuen, Rene S Hendriksen\",\"doi\":\"10.1093/jac/dkaf032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>External quality assurance (EQA) is an objective tool to assess laboratories' diagnostic performance and their adherence to recognized international standards. External Quality Assessment in Asia (EQASIA) is an EQA network in South and South-East Asia established in 2020 with the aim of improving the quality of bacteriology diagnostics across all One Health sectors in the region. The aim of this paper is to provide a comprehensive overview of the EQA results collected from the EQASIA network and to assess improvements among the participating laboratories.</p><p><strong>Methods: </strong>Six EQA rounds were conducted between 2021 and 2023, each composed of different panels of WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) and The Food and Agriculture Organization of the United Nations (FAO) priority pathogens of interest to both the human and animal health sector.</p><p><strong>Results: </strong>Between 24 and 32 laboratories signed up for six EQA rounds (EQA1-6). Participating laboratories were able to isolate and correctly identify most of the isolates across the EQA panels except for the Campylobacter spp. and Enterococcus spp. panels. The overall performance of laboratories across the six EQAs was between 75% and 100% (average 93.3% and median 93.6%). The obtained results showed a significant improvement in laboratories' performance over time.</p><p><strong>Conclusions: </strong>Laboratory capacity development and quality assurance in a microbiology laboratory are of particular importance especially in the context of antimicrobial resistance (AMR) and One Health surveillance. The EQASIA programme has the potential to validate laboratories' performance in detecting important One Health pathogens, generating reliable data for effective surveillance to curb AMR.</p>\",\"PeriodicalId\":14969,\"journal\":{\"name\":\"Journal of Antimicrobial Chemotherapy\",\"volume\":\" \",\"pages\":\"1037-1046\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-04-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11962387/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Antimicrobial Chemotherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/jac/dkaf032\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antimicrobial Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/jac/dkaf032","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

目的:外部质量保证(EQA)是一种客观的工具,用于评估实验室的诊断表现及其对公认国际标准的遵守情况。亚洲外部质量评估(EQASIA)是南亚和东南亚的一个外部质量评估网络,成立于2020年,目的是提高该地区所有“一个健康”部门的细菌学诊断质量。本文的目的是提供从EQASIA网络收集的EQA结果的全面概述,并评估参与实验室的改进。方法:在2021年至2023年期间进行了6轮EQA,每轮由世卫组织全球抗菌素耐药性和使用监测系统(GLASS)和联合国粮食及农业组织(FAO)对人类和动物卫生部门感兴趣的重点病原体的不同小组组成。结果:共有24 ~ 32家实验室报名参加了6轮EQA (EQA1-6)。除了弯曲杆菌和肠球菌外,参与的实验室能够分离并正确识别EQA面板上的大多数分离物。6个eqa的实验室总体绩效在75%到100%之间(平均93.3%,中位数93.6%)。所获得的结果表明,随着时间的推移,实验室的性能有了显著改善。结论:微生物实验室的实验室能力发展和质量保证特别重要,特别是在抗菌素耐药性(AMR)和“一个健康”监测的背景下。EQASIA项目有可能验证实验室在检测“一个健康”重要病原体方面的表现,为有效监测遏制抗生素耐药性产生可靠数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories.

Objectives: External quality assurance (EQA) is an objective tool to assess laboratories' diagnostic performance and their adherence to recognized international standards. External Quality Assessment in Asia (EQASIA) is an EQA network in South and South-East Asia established in 2020 with the aim of improving the quality of bacteriology diagnostics across all One Health sectors in the region. The aim of this paper is to provide a comprehensive overview of the EQA results collected from the EQASIA network and to assess improvements among the participating laboratories.

Methods: Six EQA rounds were conducted between 2021 and 2023, each composed of different panels of WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) and The Food and Agriculture Organization of the United Nations (FAO) priority pathogens of interest to both the human and animal health sector.

Results: Between 24 and 32 laboratories signed up for six EQA rounds (EQA1-6). Participating laboratories were able to isolate and correctly identify most of the isolates across the EQA panels except for the Campylobacter spp. and Enterococcus spp. panels. The overall performance of laboratories across the six EQAs was between 75% and 100% (average 93.3% and median 93.6%). The obtained results showed a significant improvement in laboratories' performance over time.

Conclusions: Laboratory capacity development and quality assurance in a microbiology laboratory are of particular importance especially in the context of antimicrobial resistance (AMR) and One Health surveillance. The EQASIA programme has the potential to validate laboratories' performance in detecting important One Health pathogens, generating reliable data for effective surveillance to curb AMR.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
9.20
自引率
5.80%
发文量
423
审稿时长
2-4 weeks
期刊介绍: The Journal publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, and articles in veterinary medicine likely to have an impact on global health.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信